KC Microbiome Communications Group

See this conference summary for the hot topics in microbiome drug development in Europe: biose.com/2022/04/04/the… @HansonWade #pharma #biotech #microbiome

See here for a summary of what we know about the gut-liver axis and the companies pursuing microbiome-focused therapies for liver disease: biose.com/2022/04/28/und…

Happening now! The FDA's Vaccines and Related Biological Products Advisory Committee is about to vote on the Biologics License Application from Rebiotix Inc. for its live fecal microbiota product, Rebyota. fda.gov/advisory-commi…

Takeda ends collaboration with Finch Therapeutics on two microbiome-focused IBD drug candidates: yahoo.com/entertainment/…

Vedanta Biosciences, a leading company for live biotherapeutic products, downsizes as it lets go of 20% of its employees: endpts.com/citing-challen…

4D Pharma, developer of several single-strain live biotherapeutic products, seeks buyer: pressandjournal.co.uk/fp/business/lo…

ISAPP is still accepting applications for the position of Executive Director. Find out more about the position here: isappscience.org/about/executiv…

Don't miss it! The Asia Skin Microbiome Congress in September, to be held in Singapore -- find out more here: global-engage.com/event/skin-mic…

Check out this FREE event from Naturally Informed -- Microbiome: Mastering the Market. Industry members have the opportunity to learn about the latest science & best practices for communicating about the microbiome. naturallyinformed.net/naturally-info…

Panel will cover what the microbiome field can learn from another field of pharma innovation -- advanced therapy medicinal products: microbiometimes.com/how-insights-f…

Read here about a new strategy for editing DNA within a microbial community via CRISPR-Cas9 microbiometimes.com/the-latest-maj…

New results, which herald the first instance of a microbiome company advancing to a Phase 3 trial for a dermatology application: #primary" target="_blank" rel="nofollow noopener">aobiome.com/pressreleases/…

Get up to speed on the patent dispute between two of the microbiome companies with leading live biotherapeutic products for recurrent C. difficile infection: microbiometimes.com/ferring-takes-…

Agriculture in the US has mainly focused on yield, sustainability, and providing good value to the consumer. But what if growing foods for HEALTH became a driver of agricultural innovation? Profs. Andy Benson & Bruce German share their vision here: microbiometimes.com/food-for-healt…

Global nutrition giant ADM acquires @deerlandenzymes, a leader in the probiotics & prebiotics space: businesswire.com/news/home/2021…

Oncology company focused on cell & gene therapies buys manufacturing site from CDMO Arranta Bio: fiercepharma.com/manufacturing/…

Tiffany Weir: microbiome modulation has great potential for addressing disease and it's an active area of research, so why don't we have more microbiome-targeting therapies? She argues prevention may be the most promising approach. #AgHealthSummit

NFHC is sponsoring the #AgHealthSummit Find out how we and other researchers are linking food production to biomedical research.

Regulation of food for health (including probiotics & prebiotics) is a hot topic -- learn more in our panel discussion on October 12th! Register here: next.brella.io/join/AGHS2021

Have you wondered about the best path to commercialization for your microbiome-focused product? Dr. Eileen Murphy will lead a discussion on all aspects of commercialization -- from science to funding to communications to legal. Sign up here to tune in: next.brella.io/join/AGHS2021